These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28066999)

  • 41. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.
    Quinlan SC; Pfeiffer RM; Morton LM; Engels EA
    Am J Hematol; 2011 Feb; 86(2):206-9. PubMed ID: 21264909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genotypic Detection of Epstein Barr Virus in Pediatric Transplant Recipients From India.
    Janani MK; Malathi J; Rela M; Farouk M; Padmapriya J; Madhavan HN
    Indian Pediatr; 2015 Nov; 52(11):946-50. PubMed ID: 26615341
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
    Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A; Baecklund E; Backlin C; Ekman T; Molin D; Tufveson G; Fernberg P; Sundström C; Pauksens K; Enblad G
    Acta Oncol; 2014 May; 53(5):669-79. PubMed ID: 24164103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart transplant outcomes in recipients of Centers for Disease Control (CDC) high risk donors.
    Tsiouris A; Wilson L; Sekar RB; Mangi AA; Yun JJ
    J Card Surg; 2016 Dec; 31(12):772-777. PubMed ID: 27774722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EBV-PTLD, Adenovirus, and CMV in Pediatric Allogeneic Transplants With Alemtuzumab as Part of Pretransplant Conditioning: A Retrospective Single Center Study.
    Cupit-Link MC; Nageswara Rao A; Warad DM; Rodriguez V; Khan S
    J Pediatr Hematol Oncol; 2018 Nov; 40(8):e473-e478. PubMed ID: 29620685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder.
    Hart M; Thakral B; Yohe S; Balfour HH; Singh C; Spears M; McKenna RW
    Am J Surg Pathol; 2014 Nov; 38(11):1522-9. PubMed ID: 25007145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients.
    Álvarez-López P; Riveiro-Barciela M; Oleas-Vega D; Flores-Cortes C; Román A; Perelló M; Berastegui C; Castells L; Esteban R; Buti M
    Medicine (Baltimore); 2020 Feb; 99(9):e19407. PubMed ID: 32118794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders.
    Limaye AP; Huang ML; Atienza EE; Ferrenberg JM; Corey L
    J Clin Microbiol; 1999 Apr; 37(4):1113-6. PubMed ID: 10074534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Posttransplant lymphoproliferative disorder.
    Everly MJ; Bloom RD; Tsai DE; Trofe J
    Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anaplastic large cell lymphoma in human immunodeficiency virus-infected people and solid organ transplant recipients.
    Mahale P; Weisenburger DD; Kahn AR; Gonsalves L; Pawlish K; Koch L; Tirado-Gomez M; Clarke CA; Alverson G; Shiels MS; Engels EA
    Br J Haematol; 2021 Feb; 192(3):514-521. PubMed ID: 32510592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
    Sidell D; Venick RS; Shapiro NL
    Laryngoscope; 2014 May; 124(5):1236-41. PubMed ID: 24105893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
    Martinez OM; Krams SM
    Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of Epstein-Barr virus status and post-transplant lymphoproliferative disease in pediatric thoracic transplantation.
    Harwood JS; Gould FK; McMaster A; Hamilton JR; Corris PA; Hasan A; Gennery AR; Dark JH
    Pediatr Transplant; 1999 May; 3(2):100-3. PubMed ID: 10389130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytomegalovirus transmission in mismatched solid organ transplant recipients: Are factors other than anti-viral prophylaxis at play?
    Hernandez C; Mabilangan C; Burton C; Doucette K; Preiksaitis J
    Am J Transplant; 2021 Dec; 21(12):3958-3970. PubMed ID: 34174153
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
    Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.